Oxford Lane Capital (NASDAQ: OXLCO) is a closed-end management investment company that provides tailored financing solutions to growth-stage companies in the healthcare, life sciences and technology sectors. Organized as a business development company (BDC) under the Investment Company Act of 1940, it primarily invests in senior secured loans and equity interests in privately held enterprises. The firm’s capital structure is designed to deliver attractive risk-adjusted returns through a diversified portfolio of floating-rate debt and equity holdings.
The company’s investment strategy focuses on senior secured debt, second-lien loans and selective equity co-investments in companies that exhibit strong cash flow generation and growth potential. Emphasizing medical device, biopharmaceutical and health technology innovators, Oxford Lane Capital seeks to partner with management teams to provide growth capital, acquisitions financing, and structured credit facilities. Its floating-rate loans are intended to offer protection in rising interest rate environments, while selective equity stakes allow for upside participation in high-growth enterprises.
Since its conversion to a Delaware corporation and BDC structure in mid-2017, Oxford Lane Capital has pursued a disciplined underwriting approach, targeting U.S.-based businesses with proven revenue models. The company leverages its market presence in key innovation hubs, including Boston, San Francisco and the greater New York metropolitan area, to source and structure private credit transactions.
Oxford Lane Capital is externally managed by Oxford Finance LLC, a specialty finance firm founded by industry veterans. The experienced management team at Oxford Finance oversees all investment sourcing, due diligence and portfolio monitoring, drawing on decades of sector expertise and established relationships within the private capital markets.
AI Generated. May Contain Errors.
Free OXLCO Stock Alerts